You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Review of Ongoing Activities and Challenges to Improve the Care of Patients With Type 2 Diabetes Across Africa and the Implications for the Future
|
|---|---|
| Published in |
Frontiers in Pharmacology, March 2020
|
| DOI | 10.3389/fphar.2020.00108 |
| Pubmed ID | |
| Authors |
Brian Godman, Debashis Basu, Yogan Pillay, Julius C. Mwita, Godfrey Mutashambara Rwegerera, Bene D. Anand Paramadhas, Celda Tiroyakgosi, Patrick Mbah Okwen, Loveline Lum Niba, Justice Nonvignon, Israel Sefah, Margaret Oluka, Anastasia N. Guantai, Dan Kibuule, Francis Kalemeera, Mwangana Mubita, Joseph Fadare, Olayinka O. Ogunleye, Larry A. Distiller, Enos M. Rampamba, Jeffrey Wing, Debjani Mueller, Abubakr Alfadl, Adefolarin A. Amu, Zinhle Matsebula, Aubrey Kalungia, Trust Zaranyika, Nyasha Masuka, Janney Wale, Ruaraidh Hill, Amanj Kurdi, Angela Timoney, Stephen Campbell, Johanna C. Meyer |
X Demographics
The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 4 | 44% |
| Nigeria | 1 | 11% |
| Unknown | 4 | 44% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 8 | 89% |
| Practitioners (doctors, other healthcare professionals) | 1 | 11% |
Mendeley readers
The data shown below were compiled from readership statistics for 350 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 350 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 56 | 16% |
| Student > Bachelor | 30 | 9% |
| Researcher | 28 | 8% |
| Student > Postgraduate | 20 | 6% |
| Student > Ph. D. Student | 19 | 5% |
| Other | 52 | 15% |
| Unknown | 145 | 41% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 71 | 20% |
| Nursing and Health Professions | 39 | 11% |
| Biochemistry, Genetics and Molecular Biology | 16 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 12 | 3% |
| Social Sciences | 9 | 3% |
| Other | 53 | 15% |
| Unknown | 150 | 43% |
Attention Score in Context
This research output has an Altmetric Attention Score of 20. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 September 2021.
All research outputs
#1,872,672
of 25,646,963 outputs
Outputs from Frontiers in Pharmacology
#746
of 19,993 outputs
Outputs of similar age
#45,891
of 392,282 outputs
Outputs of similar age from Frontiers in Pharmacology
#37
of 491 outputs
Altmetric has tracked 25,646,963 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 19,993 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 392,282 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 491 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.